Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy   Report issue

Academic/Hospital Phase 4
Founded: Palermo Italy (2001)

Organization Overview

First Clinical Trial
2014
NCT02409563
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy